ロード中...
Human immune globulin 10% with recombinant human hyaluronidase in multifocal motor neuropathy
OBJECTIVE: The primary aim was to determine the safety of treatment with human immune globulin 10% with recombinant human hyaluronidase (fSCIg) compared to intravenous immunoglobulin (IVIg) in a prospective open-label study in patients with multifocal motor neuropathy (MMN). METHODS: Our study consi...
保存先:
| 出版年: | J Neurol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Berlin Heidelberg
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6803588/ https://ncbi.nlm.nih.gov/pubmed/31325017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00415-019-09475-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|